Platinum-resistant ovarian cancer holds a poor prognosis and is often treated with single-agent chemotherapy. A preprint aims to determine a recommended phase 2 dose (RP2D) of the combination of paclitaxel and lapatinib. 👇 Learn more. #GynOnc #CancerResearch #Oncology #MedEd3